Replace body text: Mini-Respiratory Panels are first-line tests to help clinicians quickly diagnose respiratory infections, which contribute to a significant healthcare burden and present with nearly indistinguishable symptoms. Results have been shown to guide antibiotic selection and significantly reduce unnecessary antibiotic use. Optimize patient management with clinically actionable results.
PCR Respiratory testing is much more sensitive than culture as well as turnaround time could be the same day or within 24-48 hours.
Urinary Tract Infection - UTI
The Diagnostic Dilemma
For years physicians have used a urine culture to detect urinary tract infections. UTIs are some of the most common bacterial infections, affecting 150 million people each year worldwide.Traditional urinary cultures take a long time to get results typically 5-7 days and are not sensitive or accurate in detecting disease. In fact, urinary cultures will miss up to 2/3 of the patients that have UTI and 50% of the patients with severe urinary symptoms underlining the need for more effective methods of diagnosis. Delayed turnaround time of results and inaccuracy of the diagnostic tool cost the healthcare system over 10 billion dollars a year and create unnecessary patient anxiety and stress
A2Z Diagnostics developed and launched a UTI molecular solution that provides a timely and accurate answer. Our panel utilizes molecular techniques such as polymerase chain reaction (PCR) to identify the bacteria causing the infection. This type of test is more sensitive than traditional methods of diagnosing a UTI and can detect bacterial strains that would otherwise be missed. By extracting DNA from the patients urine sample, our PCR testing uses advanced biotechnology to identify specific targeted pathogens that most commonly are associated with urinary tract infections. In addition to our bacteria and fungal targets, we also offer antibiotic resistance marker detection which gives us the ability to test for the presence of any markers in the pathogens of interest. These antibiotic resistance markers in conjunction with our UTI panel will further assist physicians to make proper and more effective clinical evaluations and conclusions.
Molecular UTI testing can provide quick and accurate results and can be used to tailor treatment for the specific strain of bacteria causing the infection. Results are often available within hours allowing for more rapid initiation of directed treatment.Learn More
The Diagnostic Dilemma
Onychomycosis is a common disease of the nail. It is the cause of roughly 50% of nail deformities and affects approximately 14-18% of people living in the USA. Laboratory testing is important to aid in identifying the pathology of the nail deformation in order to determine a proper treatment plan. Since conditions of psoriasis and malignant melanoma can mimic the appearance of fungal infections it is very important to quickly and accurately diagnose conditions in order to treat them efficiently and effectively.
With molecular testing, not only can you receive a clear picture of the type and percent of pathogens causing the infection, in many cases, you can identify antimicrobial resistance. With the power of molecular testing, you can select the optimal medication therapy for your patient, improve treatment outcomes and reduce healthcare spend.Learn More
Gastrointestinal Pathogen Panel
GI Panel tests for 22 of the most commonly associated pathogens related to gastroenteritis—all from one patient sample, one easy to use reagent, and results are available in about one hour.
Clinicians rarely receive accurate or timely answers with traditional stool testing methods and often have to make patient management decisions without a laboratory result. With the GPP Panel, timely and accurate results are provided that have been demonstrated to lead to more targeted therapy.
The Diagnostic Dilemma
There has been a lot of improvements in wound dressings over the last few years. Despite these advancements, the diagnostic options for ruling out infection have been limited to routine culture, which like many older technologies lacks sensitivity and specificity to detect disease, is time-consuming and typically does not recognize all pathogens.
It has been the norm for patients with chronic wounds to be placed on a regime of antibiotics. This creates issues with the culture in that often times they will not grow while contributing to the global epidemic of antibiotic resistance.
A2Z Diagnostics and its team have developed and launched an industry-leading molecular wound care solution that provides timely, accurate answers through our value-based technology platform. Our panel identifies and guides appropriate treatment by identifying the genes associated with antibiotic resistance.